Skip to main content

Table 1 Socio-demographic characteristics and Chi-square analysis for demographic and behavioral correlates of oral PrEP awareness among adolescent girls and young women, Kampala, Uganda (Jan–Oct 2019)

From: Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda

  

Heard of oral PrEP

Variables (N = 285)

N (Col%)

n = 66

n (row%)

P-value

Age at enrollment, mean (SD)

19.9 (± 2.24)

  

Age group

   

 14–19

112 (39.3)

26 (23.2)

 

 20–24

173 (60.7)

40 (23.1)

0.986

Level of education

   

 None/primary

129 (45.3)

31 (24.0)

 

 Secondary/tertiary

156 (54.7)

35 (22.4)

0.751

Marital status

   

 Married

84 (29.5)

14 (16.7)

 

 Separated/divorced

38 (13.3)

10 (26.3)

 

 Single (never married)

163 (57.2)

42 (25.8)

 

Occupation

   

 Sex work

60

20 (33.3)

 

 Other

157 (55.1)

34 (21.7)

 

 No job

68 (23.9)

12 (17.7)

0.088

Alcohol consumption risk level

   

 Low risk drinking

196 (68.8)

38 (19.4)

 

 Moderate risk/ hazardous

64 (22.5)

16 (25.0)

 

 High risk/ Alcohol dependent

25 (8.80)

12 (48.0)

0.006

Illicit drug use in the last one month

   

 Yes

241 (84.6)

15 (21.2)

 

 No

44 (15.4)

51 (34.1)

0.062

Frequently stayed away from home in the last 3 months

   

 Yes

114 (40.0)

33 (28.9)

 

 No

171 (60.0)

33 (19.3)

0.059

Age at first sex

   

 9–17

228 (80.0)

58 (25.4)

 

 ≥ 18

57 (20.0)

8 (14.0)

0.068

Number of sexual partners in the last 3 months

   

 1

89 (31.2)

12 (13.5)

 

 ≥ 2

196 (68.8)

54 (27.6)

0.009

Reported consistent condom use in last 3 months

   

 Yes

209 (73.3)

44 (21.1)

 

 No

76 (26.7)

22 (28.9)

0.162

Transactional sex

   

 Yes

264 (92.6)

63 (23.9)

 

 No

21 (7.40)

3 (14.3)

0.425

STI test results (Chlamydia and Gonorrhea)

   

 Negative

210 (74.7)

46 (21.9)

 

 Positive

71 (25.3)

19 (26.8)

0.402

Contraceptive use

   

 Yes

158 (55.4)

35 (22.2)

 

 No

127 (44.6)

31 (24.4)

0.653

Willingness to use oral PrEP

   

 Yes

256 (89.8)

89.8

 

 No

29 (10.2)

10.2

 

Willingness to use injectable PrEP

   

 Yes

255 (89.5)

89.5

 

 No

30 (10.5)

10.5

Â